As COVID-19 continues to impact the world and remains a force against US MedTech firms, hold on. The pent-up demand for halted medical procedures is expected to be urgent. Yes, it remains complicated, but the medical device industry could face shortages as recovery begins.
As a global company, Oliver Healthcare Packaging (along with many others) has taken the wild ride of the COVID-19 crisis from the earliest weeks. First, our colleagues in China and Europe were impacted. Even as we knew the virus was coming to the US, our response had to be where we were in the moment. Still, those early emergencies helped inform the strategy for our US response, evoking an odd sort of gratitude.
Revenue, materials and mandatory on-site constraints remain daunting. Yet, as Daphne Allen speaks with MedTech business consultant Brian Chapman, the angst of zero visibility may be diminishing for those who can squint to see beyond the debris.
Areas of demand will include orthopedic, cardiac and all of the conditions dubbed non-emergency or elective. Areas of action include analyzing how we communicate with health care customers to ascertain how all of us can persevere to “be ready.” Let’s look to recovery, together!
